Tyra Biosciences (TYRA) Revenue & Revenue Breakdown
Tyra Biosciences Revenue Highlights
00
Tyra Biosciences Revenue by Period
Tyra Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Tyra Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $502.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Tyra Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOWL | Werewolf Therapeutics | $19.94M | $1.14M |
IKNA | Ikena Oncology | $9.16M | - |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
MOLN | Molecular Partners | $7.04M | $2.74M |
IPSC | Century Therapeutics | $2.23M | $791.00K |
DSGN | Design Therapeutics | - | - |
CGEM | Cullinan Oncology | - | - |
RAPT | RAPT Therapeutics | - | - |
CCCC | C4 Therapeutics | - | - |
GRCL | Gracell Bio | - | - |
PHVS | Pharvaris | - | - |
CNTB | Connect Biopharma | - | - |
ERAS | Erasca | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
EWTX | Edgewise Therapeutics | - | - |
TYRA | Tyra Biosciences | - | - |
XLO | Xilio Therapeutics | - | $2.36M |